Filing Details
- Accession Number:
- 0001628280-22-017642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-21 16:07:53
- Reporting Period:
- 2022-06-17
- Accepted Time:
- 2022-06-21 16:07:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434868 | Esperion Therapeutics Inc. | ESPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1766524 | L. Sheldon Koenig | C/O Esperion Therapeutics, Inc. 3891 Ranchero Drive, Suite 150 Ann Arbor MI 48108 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-06-17 | 4,552 | $4.99 | 190,165 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.
Billionaire Hedge Funds
